NEW JERSEY, NJ, UNITED STATES, May 26, 2025 /EINPresswire.com/ -- The global biosimilars market is experiencing robust growth as healthcare systems strive to improve patient access to life-saving ...

President Donald Trump announced a policy change that would mean Medicare recipients who pick a drug plan offering the new insulin benefit would pay a maximum of $35 a month starting next year. The ...

The results indicate that chloroplasts are a highly efficient vehicle for the potential production of pharmaceutical proteins in plants. Recombinant therapeutic proteins need to carry all of the ...

We used data simulation to determine the influence of population size, the effect of the degree of marker saturation of the genome, and the number of individuals required for mapping of recombinant ...

Bengaluru: Biocon Biologics Limited has announced that the Government of Malaysia has agreed to extend the current contract ...

Eris Lifesciences Ltd on Monday reported a consolidated net profit of ₹93.8 crore for the quarter ended March 2025, a 31.1% ...

As per the latest analysis, the biosimilar and biologics market value is estimated to reach USD 520.9 billion in 2024. Global sales of biosimilars and biologics will likely increase at 7.6% CAGR ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

Figure 1: Four different strategies for 7-ADCA production. Figure 5: Genetic map of the plasmid pALC88 used to introduce ring expansion activity (DAOCS) into A. chrysogenum ΔcefEF. Fermentation ...

Insulin–DNA conjugate was synthesized by resuspending recombinant insulin (Sigma-Aldrich) to make a 1 mg/mL solution in reaction buffer (55 mM sodium phosphate, 150 mM sodium chloride, 20 mM EDTA, pH ...

The state giant’s Mumbai High and several other west coast fields are facing natural production declines as they mature. ONGC has carried out four previous redevelopment phases at Mumbai High ...

Sanjay Basu, Waymark, San Francisco, California. Kasia J. Lipska, Yale University. Insulin is considered an essential medicine for people with diabetes, but its price has doubled during the past ...